Effect of Roxithromycin and Intranasal Fluticasone Spray in Reducing Symptoms of Chronic Sinusitis, Polyp Size and IL-4 in Allergic Patients

Nasal polyp is an intractable condition usually associated with chronic hyperplastic sinusitis with allergic rhinitis. IL-4 isknown to contribute to the inflammatory reaction by enhancing binding of inflammatory cells in the nasal polyp. The objectivesof this study were to evaluate the effect of roxithromycin (300 mg daily) and intranasal fluticasone spray (200 μg daily ) inreducing symptoms of chronic sinusitis and polyp size and to compare pre - and post-treatment secretion of IL-4. Twenty-fourpatients with chronic sinusitis with nasal polyp and allergic rhinitis were selected and allocated into 3 groups；roxythromycin,fluticasone propionate and combined use group. Statistically significant decrease in symptoms was observed in both theroxythromycin and fluticasone propionate groups. Significant improvement of rhinorrhea and postnasal drip was observed inthe combined use group. The polyp size decreased significantly in all three groups. IL-4 secretion decreased significantly in thecombined use group after treatment. Long term medication of roxithromycin and intranasal fluticasone spray were effectivein reducing symptoms and polyp size in chronic sinusitis with allergic rhinitis. They were also effective in reducing IL-4. KCI Citation Count: 0